Language selection

Search

Patent 1273887 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1273887
(21) Application Number: 1273887
(54) English Title: METHOD OF SUBMERSELY GROWING PSEUDOMONAS AERUGINOSA BACTERIAL STRAINS
(54) French Title: METHODE DE CULTURE DE PSEUDOMONAS AERUGINOSA EN MILIEU AQUEUX
Status: Expired and beyond the Period of Reversal
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12N 01/20 (2006.01)
  • A61K 39/104 (2006.01)
  • A61K 39/40 (2006.01)
  • A61P 31/04 (2006.01)
  • A61P 37/04 (2006.01)
  • C07K 14/21 (2006.01)
  • C12P 21/00 (2006.01)
(72) Inventors :
  • MONTIE, THOMAS C. (United States of America)
  • DORNER, FRIEDRICH (Austria)
  • MCDONEL, JAMES L. (United States of America)
  • MUNDT, WOLFGANG (Austria)
(73) Owners :
  • IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
(71) Applicants :
  • IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE (Austria)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 1990-09-11
(22) Filed Date: 1986-01-13
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
A 73/85 (Austria) 1985-01-14

Abstracts

English Abstract


ABSTRACT OF THE DISCLOSURE:
In a method of submersely growing certain H-type producing
Pseudomonas aeruginosa bacterial strains of the taxonomic
family of Pseudomonadaceae, the bacterial strains are grown
in an aequeous nutrient medium free from antigens and
proteins and containing a carbon source, a nitrogen source
and mineral salts.


Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS.
1. A method of submersely growing Pseudomonas aeruginosa
bacterial strains of the taxonomic family of Pseudo-
monadaceae, wherein the following H-type antigen pro-
ducing Pseudomonas aeruginosa bacterial strains
<IMG>
are grown in an aqueous nutrient medium, said aqueous
nutrient medium being free from antigens and free from
proteins and containing a nitrogen source and mineral
salts as well as a carbon source selected from the group
consisting of succinate and urea.
2. A method as set forth in claim 1, wherein said Pseudo-
monas aeruginosa bacterial strains are grown continuous-
ly.
3. A method as set forth in claim 1 or 2, wherein said
Pseudomonas aeruginosa bacterial strains are grown tur-
bidostatically, said nutrient medium having an oxygen
content of from 5 to 20 %, a cellular density of 2 - 3 x
- 9 -

109 cells/ml being maintained and a substrate dilutiond
rate of from 0.1 µ to 0.3 µ being maintained by
supplying fresh nutrient medium.
4. A method as set forth in claim 1, wherein said Pseudo-
monas aeruginosa bacterial strains are grown at a tem-
perature of from 20 to 35°C, a pH of from 6.5 to 7.5
being maintained.
- 10 -

Description

Note: Descriptions are shown in the official language in which they were submitted.


1;~738~7
The invention relates to a method of submersely
growing Pseudomonas aeruginosa bacterial strains of the
taxonomic familiy of the Pseudomonadaceae.
Bacterium Pseudomonas aeruginosa is opportunistic
pathogen which often occurs with hospital infections mainly
patients having a weakened immune defense, such as patients
suffering from burns, persons suffering from cystic
fibrosis or having defective organic functions, and pa-
tients suffering from tumours. Due to the occurrence of
resistances, antibiotics are active against Pseudomonas
infections to a limited extent only, and therefore attempts
are made to fight infections caused by Pseudomonas aerugi-
nosa by immunological methods.
Infections may be triggered by a plurality of strains
producing 0-group antigens and H-antigens. According to the
H-antigen pattern according to Ansorg (ZBl. Bakt. Hyg. I.
Abt. Orig. A 242, 228-238 (1978)), by using the indirect
immunofluorescence technique, with Pseudomonas aeruginosa
there is differentiated between a complex flagellar antigen
a having the partial antigens ao, al, a2~ a3/ a4, and a
uniform flagellar antigen _. The partial factors ao - a4
are independent determinants, a flagellar antigen pattern
having several H-types resulting 0-groups and H-type show
free combinations.
It is already known to produce Pseudomonas vaccines
for the prophylaxis against Pseudomonas infections, wherein
as starting materials either Pseudomonas aeruginosa bac-
terial masses themselves and/or culture filtrates which
were obtained by growing the micro-organisms on surface
cultures or submersely in complex nutrient media are used.
-- 1

~;~73&~7
With these complex nutrient media beside a carbon and
energy source (mostly carbohydrates) and essential nutri-
tive salts, various extracts and/or hydrolysates of animal,
microbial or vegetable proteins (so-called peptones) were
used. Such nutritive solution supplements are not defined
as to their exact composition, and furthermore they are
variable from lot to lot. Beside amino acids, they also
contain incompletely degraded protein fragments and un-
defined complexes of the same and serve substantially for
meeting the amino acid and growth promoting substance de-
mands. Culture supernatants, therefore, are always rich in
substances of non-bacterial origin, which has the disadvan-
tage that for preparing a flagellar antigen of Pseudomonas
aeruginosa always several separating steps, which are to
follow the cultivation step, are necessary in order to free
an immunogenically effective flagellar antigen as far as
possible from impurities stemming from the nutrient medium.
A further disadvantage of the hitherto used growing
methods in lots or batches consists in that the bacteria
are subjected to a condition of continuous physiological
change from the time of their inoculation to the time of
their separation from the culture. The trigger moment for
this physiological and thus functional differentiation of
the bacterial biomass is caused by the cellular growth
itself and by the temporal change of the composition of the
nutrient medium caused in turn by the cellular growth. The
visible result of this spontaneous physiological differen-
tiation is already recognizable by the various phases of
the growth curve of a batch culture. As a consequence of
the described direct relationship between the physiological
-- 2
' .

~3~387
activity of the cellular mass on the one hand and its
surrounding environment on the other hand, a preferred
enrichment in various intra and extra cellular metabolic
products depending on the growth phase and differentiation
phase is connected therewith. Therefore, the culture su-
pernatants of a batch culture contain an integrated mixture
of all the metabolic products formed temporally over indi-
vidual differentiation phases.
The invention aims at avoiding these difficulties and
disadvantages and has as its object to provide a method of
submersely growing strains of Pseudomonas aeruginosa bac-
teria which gives, in much higher yields than has hitherto
been the case, a bacterial biomass for a recovery of anti-
gens whose physiological state remains constant during the
total period of cultivation; in which a synthetic nutrient
medium is used from which there result no additional
impurities caused by autoclaving; and which enables an
easier chemical working up of the bacterial biomass to
flagellar antigen.
According to the invention, this object is achieved in
that the following H-type antigen producing Pseudomonas
aeruginosa bacterial strains
strain H-type
1 170001 - b
M-2 - b
2 5940 - aol a2
3 5939 - ao, a3
4 5933 _ ao, al, a2
1210 - ao~ al, a2
16990 - ao~ al, a2
-- 3 --

~3~87
170018 - ao, a3, a4
are grown in an aqueous nutrient medium, the aqueous
nutrient medium being free from antigens and free from
proteins and containing a nitrogen source and mineral
salts as well as succinate or urea as carbon source.
The carbon source mentioned has proved to be particu-
larly growth-promoting.
For the strains 170001, 5940, 5939, 5933 and 170018
the classification according too Ansorg is used. The allo-
cation of the strains M-2, 1210 and 16990, not classified
in types, to the corresponding H-serotype is effected on
the basis of comparative examinations of the molecular
weights and serological cross reactions by Montie et al.
Preferably, the Pseudomonas aeruginosa bacterial
strains are grown continuously.
According to a further preferred working method, the
Pseudomonas aeruginosa bacterial strains may be grown tur-
bidostatically, the nutrient medium having an oxygen con-
tent of from 5 to 20 %, preferably approximately 10 %, a
cellular density of 2-3 x 109 cells/ml being maintained and
a substrate dilution rate of from 0.1 ~ to 0.3 ,u being
maintained by supplying fresh nutrient medium.
The growing of Pseudomonas aeruginosa bacterial
strains according to the invention is effected under agi-
tation and airing of an "open c~llture" in a manner that
they are caused to grow maximally and form the flagellas.
The nutritive substrate is supplied in dependence on the
growth rate of the culture or on the state of equilibrium
reached by the culture. The regulation or control of the
fresh nutrient medium supply is effected in dependence on a
.

1~3~7
parameter that is proportionate to the growth of the cul-
ture, preferably the temporal change of the cellular densi-
ty. However, also other parameters which are proportionate
to the development of the culture, such as the breathing
activity, C02 production, change in the hydrogen ion con-
centration, change in the carbon source concentration,
respiration quotient, nitrogen consumption, oxygen con-
sumption and heat tone may be used. Furthermore, the supply
of fresh nutrient medium may be effected in dependence on
the amount of the antigen formed.
With the continuous growing method according to the
invention, culture liquid is withdrawn from the growing
vessel simultaneously with the supply of fresh nutrient
medium, so that between the growth and the physiologic
activity, in particular the forming of cells on the one
hand and the surrounding environment of the cells on the
other hand, there adjusts a flow equilibrium state that is
precisely definable and reproducible at any time and which
can be maintained practically for an unlimited period of
time.
As nutrient medium, a synthetic medium free from pro-
teins is used, which exclusively contains chemically as
well as physico-chemically qualitatively and quantitatively
determinable components. An inorganic nutrient solution
containing all essential elements is suitable.
With the preferred embodiment according to the inven-
tion, for the fermentative production of the germs, the
chemostatic principle of the continuous culture, in which
the physiological activity of the culture is controlled by
a limiting substrate, preferably the carbon and energy
-- 5 --

~2'7~8~7
source, as well as the turbidostatic principle of the
continuous culture, with which the dilution rate (micron)
and thus the physiological activity of the culture is
externally controlled via a growth parameter, preferably
via the instantaneous cellular density of the culture, are
applicable.
Preferably, the turbidostatic continuous cultivation
is used.
In order to promote a maximal bacterial growth, also
the temperature and the pH value are of importance; thus,
suitably, while growing of the Pseudomonas aeruginosa bac-
terial strains takes place, a temperature of from 20 to
35C, preferably 30C, and a pH of from 6.6 to 7.S, pref-
erably 7.0, are to be maintained.
In detail, the method according to the invention,
with the turbidostatic working manner, is carried out in a
fermentor, in that at first the nutrient medium is inoccu-
lated with a bacterial strain and it is proceeded under
maintenance of the conditions stated, until the cellular
density stated, of 2 - 3 x 109 cells/ml is achieved in the
logarithmic final phase. As soon as this is the case,
bacterial suspension is continuously withdrawn from the
fermentor and substituted by fresh nutrient solution.
Suitably, the dilution rate shall not be more than 0.3
preferably of from 0.1 to 0.2 ~u.
Under the conditions stated, after achieving the flow
equilibrium state, 1.5 to 2.0 g/l wet cells are obtained,
which corresponds to a turbidity value of the suspension of
from 0.5 to 0.7, prior to centrifugation at 590 nm, ac-
cording to the method by Tyndall.

1~3~
The method according to the invention shall now beexplained in more detail by way of the following example:
Example:
A nutrient solution of the following composition was
used:
Disodium succinate 4.05 g/l,
Dipotassium monohydrogen phosphate 7 g/l,
Potassium dihydrogen phosphate 3 g/l,
Ammonium hydrogen phosphate 1 g/l,
Magnesium sulfate . 7 H2O 0 05 g/l,
Ferric chloride 0.0025 g/l,
the pH was adjusted to 7.0 and the temperature was brought
to 30C. The nutrient solution was inocculated with the
strain Pseudomonas aeruginosa M-2 and introduced into a
15 1 fermentor. During a fermentation period of 96 hours,
140 1 of the nutrient medium were passed through, the air
flow rate amounting to 10 % P02 (oxygen partial pressure).
The dilution rate was 0.1 tU. The cellular density amounted
to 2-3 x 109 cells/ml after the flow equilibrium state had
been reached.
Under the same conditions, the strains 170001 and
1210 were cultivated, the following table giving the cul-
ture conditions, dilution rate, oxygen partial pressure in
% and cell yield in g/l wet weight after centrifuging twice
at 15,000 x g. Furthermore, the turbidity values of the
suspension prior to centrifuging are given.

~73~
Culture
Strain conditions Cell yield
Dilution Oxygen Turbidity value g/l wet
rate content at 590 nm;d=lcm cells
_ ~
170001 0.1 ~ 10 % PO2 0.6 - 0.67 1.7
M-2 0.1 y 10 % PO2 0.6 - 0.7 1.6 - 1.7
1210 0.1 ~ 10 % PO2 0.55 - 0.65 1.5 - 1.6
1210 0.2 ~ 10 % PO2 0.6 1.5 - 1.6

Representative Drawing

Sorry, the representative drawing for patent document number 1273887 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC assigned 2023-03-22
Inactive: IPC assigned 2023-03-22
Inactive: IPC assigned 2023-03-22
Inactive: IPC assigned 2020-06-16
Inactive: IPC assigned 2020-06-16
Time Limit for Reversal Expired 2005-09-12
Letter Sent 2004-09-13
Inactive: IPC removed 1994-12-31
Grant by Issuance 1990-09-11

Abandonment History

There is no abandonment history.

Fee History

Fee Type Anniversary Year Due Date Paid Date
MF (category 1, 7th anniv.) - standard 1997-09-11 1997-07-21
MF (category 1, 8th anniv.) - standard 1998-09-11 1998-07-27
MF (category 1, 9th anniv.) - standard 1999-09-13 1999-07-27
MF (category 1, 10th anniv.) - standard 2000-09-11 2000-08-25
MF (category 1, 11th anniv.) - standard 2001-09-11 2001-08-20
MF (category 1, 12th anniv.) - standard 2002-09-11 2002-08-20
MF (category 1, 13th anniv.) - standard 2003-09-11 2003-08-21
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
Past Owners on Record
FRIEDRICH DORNER
JAMES L. MCDONEL
THOMAS C. MONTIE
WOLFGANG MUNDT
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1993-10-07 1 9
Claims 1993-10-07 2 33
Drawings 1993-10-07 1 19
Descriptions 1993-10-07 8 236
Maintenance Fee Notice 2004-11-07 1 173
Fees 1992-08-30 1 25
Fees 1995-07-26 1 39
Fees 1993-06-28 1 29
Fees 1996-07-22 1 41
Fees 1994-07-19 1 36